|
ZKSCAN5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23359997164607E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.61880000035953E-07 |
| Normal-vs-Stage2 |
5.228000E-02 |
| Normal-vs-Stage3 |
2.938800E-01 |
| Normal-vs-Stage4 |
5.192200E-01 |
| Stage1-vs-Stage2 |
5.241400E-01 |
| Stage1-vs-Stage3 |
1.193200E-01 |
| Stage1-vs-Stage4 |
3.449000E-01 |
| Stage2-vs-Stage3 |
1.618220E-01 |
| Stage2-vs-Stage4 |
3.184600E-01 |
| Stage3-vs-Stage4 |
9.585400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70539999899688E-08 |
| Normal-vs-AfricanAmerican |
7.041100E-04 |
| Normal-vs-Asian |
3.502400E-01 |
| Caucasian-vs-AfricanAmerican |
7.103200E-01 |
| Caucasian-vs-Asian |
5.381000E-01 |
| AfricanAmerican-vs-Asian |
5.130200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.83579998267203E-09 |
| Normal-vs-Female |
1.966450E-04 |
| Male-vs-Female |
6.824000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.536500E-02 |
| Normal-vs-Extreme_Weight |
6.633700E-04 |
| Normal-vs-Obese |
7.66469999999853E-05 |
| Normal-vs-Extreme_Obese |
2.516400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.013200E-01 |
| Normal_Weight-vs-Obese |
1.435650E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.842400E-01 |
| Extreme_Weight-vs-Obese |
3.368600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.176000E-01 |
| Obese-vs-Extreme_Obese |
5.666000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.382830E-03 |
| Normal-vs-Age(41-60Yrs) |
3.51119999741911E-09 |
| Normal-vs-Age(61-80Yrs) |
3.61720000000565E-05 |
| Normal-vs-Age(81-100Yrs) |
7.782400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.312600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.964000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.985000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.874840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.857700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.667800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-15 |
| Normal-VS-Type2 PRCC |
9.438400E-01 |
| Normal-VS-KIRP CIMP |
7.028400E-01 |
| Normal-VS-Unclassified PRCC |
1.561980E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.31500000280604E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.402500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.240400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.783400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.576100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.931800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.316000E-01 |
| Normal-vs-N1 |
1.433830E-01 |
| Normal-vs-N2 |
8.082200E-01 |
| N0-vs-N1 |
5.997800E-01 |
| N0-vs-N2 |
6.335200E-01 |
| N1-vs-N2 |
4.670600E-01 |
|
|
